VIDEO: Teriflunomide and dimethyl fumarate are comparable in relapsing-remitting MSFebruary 9, 2018Multiple Sclerosis
‘Real-world evidence’ used to compare agents for relapsing-remitting MSFebruary 7, 2018Multiple Sclerosis
Rituximab May Provide Greater Benefits Than Other First-Line MS TherapiesFebruary 5, 2018Multiple Sclerosis
Generic Glatiramer Acetate Remains Safe and Effective for Two YearsJanuary 17, 2018Multiple Sclerosis
Rituximab may outperform some other first-line multiple sclerosis treatmentsJanuary 8, 2018Multiple Sclerosis
